Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention
A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure
Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
Basic Biology of Oxidative Stress and the Cardiovascular System: Part 1 of a 3-Part Series
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.